Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06361407 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sensory and Cognitive Predictions, and Their Disruptions in Schizophrenia

Study acronym: SensoSchiz
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Apr 30, 2027 to Oct 28, 2027
    • Study sites: 0 to 2
    • Study completion date: Feb 28, 2028 to Oct 28, 2027
    • Start date changed from estimate of Sep 1, 2024 to Jun 28, 2024
  2. Start date: May 1, 2024 to Sep 1, 2024v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Disturbances in the sense of self and time could play an important role in the development of psychotic symptoms. Previous work has shown that patients have difficulty preparing to process information on the scale of a second, but are abnormally disturbed by slightly asynchronous information on the millisecond scale. In both cases, the anomalies could explain the patients' unusual experience of time. The hypothesis in neurotypical patients is that small delays or asynchronies asynchronies are treated as irrelevant information and ignored and ignored, whereas in patients suffering from schizophrenia they would disrupt the flow of time. This hypothesis is tested with a new visual illusion.
Trial Details
NCT Number NCT06361407
Lead Sponsor Centre Psychothérapique de Nancy
Collaborators: Institut National de la Santé Et de la Recherche Médicale, France
Conditions
(from sponsor)		 Schizophrenia, Sensory Processing Disorder
Related terms Schizophrenia
Enrollment 68 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov